Medicare Part D claims significantly underreport opioid dispensing for patients admitted to skilled nursing facilities after hospitalizations, according to a September research letter published in the ...
For patients recovering from opioid use disorder, particularly from drugs like fentanyl or heroin, the days immediately following a hospital stay are among the most dangerous. A new multi-state study ...
America’s overdose crisis isn’t the simple story we’ve been told for years. A new investigation reveals how two key graphs — ...
Opioids are still widely prescribed, but have limited effectiveness and are associated with serious harms. De-prescribing ...
Buprenorphine dramatically lowers overdose risk among teenagers and young adults. However, it’s more effective when taken for ...
The Tanweer Festival returns to Sharjah's Mleiha Desert from 21–23 November 2025, bringing together 183 musicians and creators from 23 countries for a celebration of artistic innovation and cultural ...
A new research letter published in JAMA Health Forum highlights major gaps in how opioid use is tracked among older adults receiving post-acute care under Medicare. Researchers found that Medicare ...
Members of the Sackler family who own OxyContin maker Purdue Pharma must pay billions of dollars to settle a flood of ...
Revenue Increased to $635,224 in Q3 2025, Compared to $0 for Q3 2024 Achieved a Reduced Net Loss of $808,502 in Q3 2025, Down From $1.5 Million in Q3 2024 ANAHEIM, CA - November 18, 2025 (NEWMEDIAWIRE ...
Today Emergent BioSolutions (NYSE: EBS) recognizes the 10-year anniversary of the U.S. Food and Drug Administration (FDA) approval of NARCAN® (naloxone HCl) Nasal Spray as the first FDA-approved nasal ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results